Drug Pipeline

Dobutamine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT05267886 CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock Shock, Cardiogenic Recruiting
Phase 2
NCT07406477 The PROTECT-HIE Pilot Trial Hypoxic-ischemic Encephalopathy (HIE) Not Yet Recruiting
Phase 1/2
NCT06318260 Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid… ATTR Amyloidosis Wild Type Recruiting
Sponsors Running Dobutamine Trials
Ottawa Heart Institute Research Corporation (1) Steen Hvitfeldt Poulsen (1) University of Alberta (1)
Disease Areas
Amyloidosis (1)
Get alerts when Dobutamine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free